Concepedia

David Fischer

DF

33

Publications

1.9K

Citations

22

H-Index

1976

Active since

Affiliations

Ono Pharmaceutical (United States)(Current)

University of Cincinnati

Evolva (Switzerland)

University of Zurich

Pfizer (United States)

David Fischer is an author at Ono Pharmaceutical (United States) specializing in medicine, biochemistry, and cell biology.

Top concepts

Publications per year

1976–2022

33

Publications

33

Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases

Florian Rosenthal, Karla L. H. Feijs, Emilie Frugier et al. · Nature Structural & Molecular Biology · 2013 · 309 citations

, , +4

Phosphohexosyl recognition is a general characteristic of pinocytosis of lysosomal glycosidases by human fibroblasts.

A Kaplan, David Fischer, Daniel T. Achord et al. · Journal of Clinical Investigation · 1977 · 181 citations · Full text

A role for adenosine deaminase in human monocyte maturation.

David Fischer, Martin B Van Der Weyden, Ralph Snyderman et al. · Journal of Clinical Investigation · 1976 · 154 citations · Full text

, , +16

High-throughput generation and engineering of recombinant human antibodies

Barbara Krebs, Robert Rauchenberger, Silke U. Reiffert et al. · Journal of Immunological Methods · 2001 · 153 citations

, , +8

Metabolic engineering of Saccharomyces cerevisiae for de novo production of dihydrochalcones with known antioxidant, antidiabetic, and sweet tasting properties

Michael Eichenberger, Beata Joanna Lehka, Christophe Folly et al. · Metabolic Engineering · 2016 · 115 citations · Full text

Rows per page

1–5 of 33